The latest guidelines from multiple professional societies—including NCCN, ASCO, the Barcelona Clinic, and the American Association for the Study of Liver Diseases—recommend strongly that patients with hepatocellular carcinoma...
For patients with high-risk hepatocellular carcinoma (HCC), adjuvant therapy with two monoclonal antibodies prolongs recurrence-free survival (RFS), according to a study presented at the annual meeting of the American...
ChatGPT provides easy-to-understand information about basic knowledge, lifestyle, and treatments for liver cancer, according to a study published in Clinical and Molecular Hepatology. Alexander Kuo, MD, and colleagues examined...
More often, it seems that hospitals and CME providers are offering resiliency training courses to doctors and other healthcare professionals as a fix for the increasing tide of burnout. In a study conducted by Medscape, the...